Egbuna O, Cheung AM, Siddhanti S, Wang A, Daizadeh N, Anthony MS. Treatment of osteoporosis by RANKL inhibition with denosumab in women at high cardiovascular risk and with renal impairment does not accelerate vascular calcification. J Am Soc Nephrol. 2010;21:640A-1A.
Doughty N, McKenna SP, Meads D, Doward LC, Pepke-Zaba J. Interim validation studies of new quality of life (QOL) and health-related quality of life (HRQL) measures specific to pulmonary arterial hypertension (PAH). Thorax. 2003;58(S3):84.
Adams MR, Golden DL, Anthony MS, Williams JK. Inhibitory effects of soy protein isolate on atherosclerosis in mice do not require the presence of LDL receptors or effects on plasma lipoproteins. J Nutr. 2002;132:602S.
Clarkson TB, Anthony MS, Register TC, Williams JK. A comparison of the effects of conjugated equine estrogens, tamoxifen, and raloxifene on coronary artery atherosclerosis of a postmenopausal nonhuman primate model. Fertil Steril. 1998;70(Suppl 1):S23.
Williams JK, Sukhova Gk, Anthony MS, Libby P. The cholesterol-lowering independent effects of pravastatin on the artery wall of monkeys. Circulation. 1997;96(Suppl I):I-607.
Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk. J Nutr. 1995 Mar;125(Suppl 3):803S-4S.
Honoré EK, Williams JK, Anthony MS. Enhancement of coronary vasodilation by soy phytoestrogens. Circulation. 1995;92(Suppl I):I-349.
Cefalu WT, Wagner JD, Anthony MS. Hyperinsulinemia and central obesity in a non-human primate (macaca fascicularis) model for cardiovascular risk factors. Clin Res Cardiol. 1992;40:230A.